In conclusion, hBMSCs-derived exosomal miR-205 could potentially be transferred to prostate cancer cells, thus inhibiting proliferation, invasion, and migration of prostate cancer cells, and promoting their apoptosis via suppression of RHPN2 (Fig. 10). Here, RHPN2 is linked to prostate cancer.